108 studies found for:    johnstown
Show Display Options
Rank Status Study
1 Completed
Has Results
Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer
Conditions: Stage II Squamous Cell Carcinoma of the Nasopharynx;   Stage III Lymphoepithelioma of the Nasopharynx;   Stage III Squamous Cell Carcinoma of the Nasopharynx;   Stage IV Lymphoepithelioma of the Nasopharynx;   Stage IV Squamous Cell Carcinoma of the Nasopharynx
Interventions: Radiation: 3-dimensional conformal radiation therapy;   Radiation: intensity-modulated radiation therapy;   Biological: bevacizumab;   Drug: cisplatin;   Drug: fluorouracil
2 Recruiting Intensity-Modulated Radiation Therapy and Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Anaplastic Thyroid Cancer
Condition: Anaplastic Thyroid Cancer
Interventions: Drug: paclitaxel;   Drug: pazopanib hydrochloride;   Other: placebo;   Radiation: intensity-modulated radiation therapy
3 Active, not recruiting Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery
Condition: Breast Cancer
Interventions: Radiation: Whole breast irradiation delivered by 3-dimensional conformal radiation therapy or intensity modulated radiation therapy;   Radiation: Higher per daily radiation therapy;   Radiation: Concurrent boost radiotherapy;   Radiation: Standard per daily radiation therapy;   Radiation: Sequential boost radiotherapy
4 Active, not recruiting Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
Conditions: Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Cognitive/Functional Effects
Interventions: Drug: temozolomide;   Biological: bevacizumab;   Other: placebo;   Radiation: intensity-modulated radiation therapy;   Radiation: 3-dimensional conformal radiation therapy;   Other: quality-of-life assessment;   Other: laboratory biomarker analysis;   Procedure: dynamic susceptibility contrast-enhanced magnetic resonance imaging;   Procedure: dynamic contrast-enhanced magnetic resonance imaging
5 Active, not recruiting Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumors
Conditions: Adult Anaplastic Oligodendroglioma;   Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Adult Oligodendroglioma;   Recurrent Adult Brain Tumor
Interventions: Biological: bevacizumab;   Biological: trebananib;   Other: placebo;   Other: pharmacological study;   Other: laboratory biomarker analysis
6 Recruiting Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer
Conditions: Adenocarcinoma of the Esophagus;   Adenocarcinoma of the Gastroesophageal Junction;   Stage IB Esophageal Cancer;   Stage IIA Esophageal Cancer;   Stage IIB Esophageal Cancer;   Stage IIIA Esophageal Cancer;   Stage IIIB Esophageal Cancer
Interventions: Radiation: radiation therapy;   Drug: paclitaxel;   Drug: carboplatin;   Biological: trastuzumab;   Procedure: therapeutic conventional surgery;   Other: laboratory biomarker analysis;   Other: quality-of-life assessment
7 Active, not recruiting Bendamustine in Combination With Lenalidomide and Dexamethasone in Refractory or Relapsed Multiple Myeloma
Condition: Myeloma
Interventions: Drug: Bendamustine;   Drug: Lenalidomide;   Drug: Dexamethasone;   Drug: Aspirin;   Drug: Prophylaxis;   Drug: Antibiotic;   Other: Biweekly Follow Up;   Other: Cyclical Follow Up;   Other: Restaging;   Other: Post-Treatment Follow Up
8 Withdrawn Trial of Radiotherapy and Panitumumab in Salivary Gland Malignancies
Conditions: Adenoma, Pleomorphic;   Mixed Salivary Gland Tumor;   Salivary Gland Tumor, Mixed;   Syringoma, Chondroid
Interventions: Radiation: Radiation;   Drug: Panitumumab
9 Completed
Has Results
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Condition: Small Cell Lung Cancer
Intervention: Drug: RAD001 (everolimus)
10 Completed Phase II Trial of Doxorubicin and Bortezomib in Patients With Incurable Adenoid Cystic Carcinoma of the Head and Neck
Condition: Adenoid Cystic Carcinoma
Intervention: Drug: doxorubicin and bortezomib
11 Completed Comparative Study Between Continuous Epidural Anesthesia And Continuous Spinal Anesthesia Using Wiley™ Spinal Catheter
Condition: Anesthesia; Adverse Effect, Spinal and Epidural
Interventions: Device: Epidural (B. Braun);   Device: Spinal (Wiley Spinal Catheter)
12 Unknown  An Open-Label Safety Study Of DIC075V (Intravenous Diclofenac Sodium) In Patients With Acute Post-Operative Pain
Condition: Pain, Postoperative
Intervention: Drug: DIC075V  (intravenous diclofenac sodium)
13 Completed Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Drug: FOLFOX regimen;   Drug: fluorouracil;   Drug: leucovorin calcium;   Drug: oxaliplatin
14 Completed A Study To Compare Pregabalin/PF-00489791 Combination Versus Pregabalin Alone In Post-Herpetic Neuralgia
Condition: Postherpetic Neuralgia
Interventions: Drug: pregabalin;   Drug: pregabalin/PF-00489791;   Drug: Placebo
15 Completed A Study of Single-Dose Gabapentin in Subjects With Transient Insomnia Induced by a Sleep Phase Advance
Condition: Transient Insomnia
Interventions: Drug: Gabapentin;   Drug: Placebo
16 Withdrawn Use of the PEAK PlasmaBlade 4.0 in Bilateral Breast Reduction
Condition: Macromastia (Symptomatic)
Interventions: Device: PEAK PlasmaBlade;   Procedure: Scalpel and Traditional Electrosurgery
17 Terminated
Has Results
Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma Histology
Conditions: Carcinoma, Squamous Cell;   Carcinoma, Adenosquamous;   Carcinoma, Large Cell;   Carcinoma, Non-Small-Cell Lung
Interventions: Drug: CP-751,871 (Figitumumab);   Drug: Carboplatin;   Drug: Paclitaxel
18 Completed The Effects of Vitamin D and Bone Loss in Parkinson's Disease
Condition: Parkinson Disease
Interventions: Dietary Supplement: Vitamin D3;   Other: Placebo
19 Completed Paclitaxel and Estramustine in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Drug: estramustine phosphate sodium;   Drug: paclitaxel
20 Active, not recruiting Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain
Condition: Low Back Pain
Interventions: Drug: Oxycodone/Naloxone controlled-release;   Drug: Oxycodone HCl controlled-release;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years